Stephen Cornelissen: You Might Be Eligible to Donate Blood – Here’s Why It’s Worth Checking
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, reposted from Australian Red Cross Lifeblood on LinkedIn:
”It’s striking how many people rule themselves out of donating blood and plasma without needing to.
Eligibility criteria can seem complex, but in reality, many more Australians are able to donate at Australian Red Cross Lifeblood than they realise.
Helping people get clear, reliable answers is an important part of making donation more accessible – and encouraging conversations that lead to life‑saving appointments.
If you’ve ever wondered whether you’re eligible, or know someone who has, it’s worth checking.
A simple conversation can be the first step toward helping a patient in need.”
Quoting Australian Red Cross Lifeblood ‘s post:
”A lot of Aussies are ruling themselves out without needing to.
6% think they’re ineligible even though they’re eligible (that’s 1.6 million people). Another 6% don’t know either way.
When asked about health conditions and eligibility criteria, over 40% got it wrong or weren’t sure.
You might be more eligible than you think and Jamie can help.
Bring Jamie into your convo with a mate and get eligibility answers in seconds.
Stats reflect eligibility as of 2021.”

Stay updated with Hemostasis Today.
-
May 27, 2026, 13:56Suzan Osman: The Major Types of Intracranial Hemorrhage in Clinical Practice
-
May 27, 2026, 13:55Raimundo C. Santos: The Main Aggressors of the Aorta and What These Lead to
-
May 27, 2026, 13:54Pooja Choradia: 2026 Acute Pulmonary Embolism Clinical Guidelines
-
May 27, 2026, 13:53Rehab Hussein: Blood Bank Training and the Clinical Responsibility of Preserving Human Life
-
May 27, 2026, 13:42New EAS Consensus Highlights Advances in Pediatric FH Care
-
May 27, 2026, 13:10Amos Gitonga Mbaabu: Global Partnerships Supporting Hemophilia and Sickle Cell Care in Africa
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome